title: In vivo and ex vivo EPR detection of spin-labelled ovalbumin in mice.
abstract: In this study, spin-labelled ovalbumin (SL-OVA), free or entrapped in liposomes, was administered to mice subcutaneously (s.c.) or intravenously (i.v.) with the aim to determine the conditions for pharmacokinetic studies of spin-labelled proteins by EPR and to measure the time course of SL-OVA distribution in vivo in live mice and ex vivo in isolated organs. Upon s.c. administration, the decay of the EPR signal was followed for 60min at the site of application using an L-band EPR spectrometer. Within this time period, the signal of free SL-OVA was diminished by about 70%. It was estimated with the help of the oxidizing agent K(3)[(FeCN)(6)] that approximately 30% was a consequence of the spin label reduction to EPR non-visible hydroxylamine and about 40% was due to the SL-OVA elimination from the site of measurement. For liposome encapsulated SL-OVA, the intensity diminished only by approx. 40% in the same period, indicating that liposomes successfully protect the protein from reduction. EPR signal could not be detected directly over live mouse organs within 60min after s.c. application of SL-OVA. With the available L-band EPR spectrometer, the measurements at the site of s.c. application are possible if the amount of SL-OVA applied to a mouse is more than 3mg. For the pharmacokinetic studies of the protein distribution in organs after s.c. or i.v. injection the concentration of the spin-labelled protein should be more than 0.5mmol/kg. After i.v. administration, only ex vivo measurements were possible using an X-band EPR spectrometer, since the total amount of SL-OVA was not sufficient for in vivo detection and also because of rapid reduction of nitroxide. After 2min, the protein was preferentially distributed to liver and, to a smaller extent, to spleen.
authors.affiliation: Jozef Stefan Institute, Laboratory of Biophysics, Jamova 39, Ljubljana, Slovenia.
authors.forename: Zrinka
authors.initials: Z
authors.lastname: Abramović
authors.forename: Marija
authors.initials: M
authors.lastname: Brgles
authors.forename: Lidija
authors.initials: L
authors.lastname: Habjanec
authors.forename: Jelka
authors.initials: J
authors.lastname: Tomasić
authors.forename: Marjeta
authors.initials: M
authors.lastname: Sentjurc
authors.forename: Ruza
authors.initials: R
authors.lastname: Frkanec
mesh_terms: D000818:Animals; D004578:Electron Spin Resonance Spectroscopy / Q000379:methods*; D005240:Feasibility Studies; D005260:Female; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008081:Liposomes / Q000737:chemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics*; D013113:Spin Labels
chemical_list: D008081:Liposomes; D013113:Spin Labels; D010047:Ovalbumin